Pediatrix Medical Group (MD) Competitors $14.18 +0.03 (+0.20%) Closing price 03/21/2025 03:59 PM EasternExtended Trading$14.20 +0.02 (+0.12%) As of 03/21/2025 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MD vs. AMED, AMN, CCRN, LH, DGX, DVA, CHE, CRVL, SEM, and EHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Select Medical (SEM), and Encompass Health (EHC). Pediatrix Medical Group vs. Amedisys AMN Healthcare Services Cross Country Healthcare Laboratory Co. of America Quest Diagnostics DaVita Chemed CorVel Select Medical Encompass Health Amedisys (NASDAQ:AMED) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment. Which has more volatility and risk, AMED or MD? Amedisys has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.49, suggesting that its share price is 49% more volatile than the S&P 500. Does the MarketBeat Community prefer AMED or MD? Pediatrix Medical Group received 12 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.21% of users gave Pediatrix Medical Group an outperform vote while only 58.58% of users gave Amedisys an outperform vote. CompanyUnderperformOutperformAmedisysOutperform Votes49558.58% Underperform Votes35041.42% Pediatrix Medical GroupOutperform Votes50760.21% Underperform Votes33539.79% Is AMED or MD more profitable? Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -4.92%. Pediatrix Medical Group's return on equity of 15.47% beat Amedisys' return on equity.Company Net Margins Return on Equity Return on Assets Amedisys3.57% 12.20% 6.74% Pediatrix Medical Group -4.92%15.47%5.64% Do institutionals and insiders believe in AMED or MD? 94.4% of Amedisys shares are owned by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are owned by institutional investors. 2.1% of Amedisys shares are owned by company insiders. Comparatively, 2.0% of Pediatrix Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer AMED or MD? In the previous week, Pediatrix Medical Group had 5 more articles in the media than Amedisys. MarketBeat recorded 9 mentions for Pediatrix Medical Group and 4 mentions for Amedisys. Pediatrix Medical Group's average media sentiment score of 1.21 beat Amedisys' score of 1.16 indicating that Pediatrix Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amedisys 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pediatrix Medical Group 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, AMED or MD? Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedisys$2.35B1.29-$9.75M$1.3170.52Pediatrix Medical Group$2.01B0.60-$60.41M-$1.20-11.82 Do analysts rate AMED or MD? Amedisys currently has a consensus target price of $100.75, indicating a potential upside of 9.06%. Pediatrix Medical Group has a consensus target price of $17.08, indicating a potential upside of 20.49%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedisys 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 SummaryPediatrix Medical Group beats Amedisys on 10 of the 18 factors compared between the two stocks. Remove Ads Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupHospitals IndustryMedical SectorNYSE ExchangeMarket Cap$1.22B$4.38B$5.73B$19.56BDividend YieldN/A1.09%4.39%3.77%P/E Ratio-11.8110.6024.7133.48Price / Sales0.600.94399.1028.54Price / Cash4.917.7938.1617.54Price / Book1.592.157.104.56Net Income-$60.41M$212.93M$3.20B$1.02B7 Day Performance3.45%1.01%1.98%0.95%1 Month Performance-8.93%-5.13%3.59%-3.88%1 Year Performance52.12%12.17%14.49%5.93% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group1.2049 of 5 stars$14.18+0.2%$17.08+20.5%+52.1%$1.22B$2.01B-11.815,170Positive NewsHigh Trading VolumeAMEDAmedisys2.5697 of 5 stars$92.64+0.1%$100.75+8.8%+0.2%$3.04B$2.35B36.7620,000Positive NewsAMNAMN Healthcare Services4.2797 of 5 stars$24.63-7.9%$41.17+67.1%-62.3%$940.60M$2.98B-6.403,585CCRNCross Country Healthcare3.3168 of 5 stars$15.32-1.7%$18.41+20.1%-19.1%$502.70M$1.34B-306.342,700Analyst ForecastNews CoveragePositive NewsLHLaboratory Co. of America4.7663 of 5 stars$240.43+0.4%$268.38+11.6%+9.7%$20.12B$13.01B27.2675,500Positive NewsDGXQuest Diagnostics4.9547 of 5 stars$173.62+2.0%$178.23+2.7%+29.1%$19.27B$9.87B22.5848,000Analyst ForecastInsider TradeShort Interest ↓Analyst RevisionNews CoverageDVADaVita4.1487 of 5 stars$149.22+4.0%$166.33+11.5%+10.5%$11.94B$12.82B13.8970,000Analyst DowngradeNews CoveragePositive NewsCHEChemed4.8309 of 5 stars$608.63+1.7%$667.00+9.6%-8.4%$8.91B$2.43B30.7515,087Positive NewsCRVLCorVel1.0604 of 5 stars$106.21-0.4%N/A+24.9%$5.45B$871.31M62.484,230News CoveragePositive NewsSEMSelect Medical4.9911 of 5 stars$17.15+2.3%$27.25+58.9%-42.4%$2.21B$5.19B10.4054,600Short Interest ↑Positive NewsEHCEncompass Health4.7009 of 5 stars$97.73+1.8%$107.67+10.2%+26.9%$9.84B$5.37B21.9135,000Short Interest ↑Positive News Remove Ads Related Companies and Tools Related Companies AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors CRVL Competitors SEM Competitors EHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MD) was last updated on 3/23/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MD Stock Free MD Stock Alerts